Cal State Fullerton expert: SHIELD-ing yourself against Alzheimer’s

By Math P. Cuajungco
The news is all too familiar – another Alzheimer’s disease drug trial bites the dust.
In the past several years, major pharmaceutical and biotechnology companies have announced failure after failure of their lead-candidate drug to halt the cognitive decline associated with Alzheimer’s disease patients initially diagnosed with mild cognitive impairment.
The impetus to treat sufferers at the early stages of the disease came about from lessons learned from sim